Award Year / Program / Phase:
2006 / STTR / Phase I
Agency:
HHS
Research Institution:
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
DESCRIPTION (provided by applicant): A new fluorescent analogue of d-glucose, 2-[N-(7-nitrobenz-2-oxa-1,3-diaxol-4-yl)amino]-2- deoxyglucose (2-NBDG), was recently developed, but has not been characterized as a marker of glucose uptake in cancer cells. Validating this new tracer as a glucoseā¦
More